Clinical trial
Frusemide Infusion for the Prevention of Deterioration in Renal Function Post…
NCT00246675 · Melbourne Health, Other · Withdrawn
Key facts
| NCT number | NCT00246675 |
|---|---|
| Title | Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery. |
| Official title | Frusemide Infusion for the Prevention of Deterioration of Renal Function in Post Cardiac Surgery |
| Lead sponsor | Melbourne Health, Other |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Renal Impairment After Cardiac Surgery |
| Intervention type | Drug |
| Interventions | Frusemide |
| Enrollment | 0 |
| First posted | Oct 31, 2005 |
| Last update posted | Apr 27, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: